Skip to main content

Clinical Trial Summaries

Clinical Trial Summaries

Stay up to date with our series of “At a glance” clinical trial summaries, which provide a brief overview of clinical trials in your specialty for quick and easy reference. Each summary is prepared using data from peer-reviewed publications and congress presentations.

At a glance: The DESTINY-Breast trials

The antibody–drug conjugate trastuzumab deruxtecan is being investigated in the DESTINY-Breast trials for the treatment of breast cancer.

At a glance: The TRAILBLAZER trials

Donanemab as a treatment for Alzheimer’s disease.

At a glance: The QWINT trials

Novel weekly insulin efsitora alfa in people with diabetes.

Stay up to date with clinical trials

Receive newsletters curated for the busy specialist by our expert editorial team.

At a glance: The KEYNOTE trials

A quick guide to the KEYNOTE trials investigating the anti-PD-1 agent pembrolizumab in non-small-cell and small-cell lung cancer.

At a glance: The STEP trials

Weekly injectable GLP-1 receptor agonist semaglutide in people with obesity.

At a glance: The ONWARDS trials

Novel weekly insulin icodec in people with diabetes.

At a glance: The CheckMate trials

A round-up of the CheckMate trials evaluating the PD-1 inhibitor nivolumab in non-small-cell lung cancer and small-cell lung cancer.